pCBASceI Citations (159)
Originally described in: Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations.Richardson C, Moynahan ME, Jasin M Genes Dev. 1998 Dec 15. 12(24):3831-42. PubMed Journal
Articles Citing pCBASceI
| Articles |
|---|
| DNA-PK, ATM and ATR collaboratively regulate p53-RPA interaction to facilitate homologous recombination DNA repair. Serrano MA, Li Z, Dangeti M, Musich PR, Patrick S, Roginskaya M, Cartwright B, Zou Y. Oncogene. 2013 May 9;32(19):2452-62. doi: 10.1038/onc.2012.257. Epub 2012 Jul 16. PubMed |
| Triapine disrupts CtIP-mediated homologous recombination repair and sensitizes ovarian cancer cells to PARP and topoisomerase inhibitors. Lin ZP, Ratner ES, Whicker ME, Lee Y, Sartorelli AC. Mol Cancer Res. 2014 Mar;12(3):381-93. doi: 10.1158/1541-7786.MCR-13-0480. Epub 2014 Jan 10. PubMed |
SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint.
Carvalho S, Vitor AC, Sridhara SC, Martins FB, Raposo AC, Desterro JM, Ferreira J, de Almeida SF.
Elife. 2014 May 6;3:e02482. doi: 10.7554/eLife.02482.
PubMed
Associated Plasmids |
| Assaying break and nick-induced homologous recombination in mammalian cells using the DR-GFP reporter and Cas9 nucleases. Vriend LE, Jasin M, Krawczyk PM. Methods Enzymol. 2014;546:175-91. doi: 10.1016/B978-0-12-801185-0.00009-X. PubMed |
| Spindle Checkpoint Factors Bub1 and Bub2 Promote DNA Double-Strand Break Repair by Nonhomologous End Joining. Jessulat M, Malty RH, Nguyen-Tran DH, Deineko V, Aoki H, Vlasblom J, Omidi K, Jin K, Minic Z, Hooshyar M, Burnside D, Samanfar B, Phanse S, Freywald T, Prasad B, Zhang Z, Vizeacoumar F, Krogan NJ, Freywald A, Golshani A, Babu M. Mol Cell Biol. 2015 Jul 15;35(14):2448-63. doi: 10.1128/MCB.00007-15. Epub 2015 May 11. PubMed |
| The NEK1 interactor, C21ORF2, is required for efficient DNA damage repair. Fang X, Lin H, Wang X, Zuo Q, Qin J, Zhang P. Acta Biochim Biophys Sin (Shanghai). 2015 Oct;47(10):834-41. doi: 10.1093/abbs/gmv076. Epub 2015 Aug 18. PubMed |
| ATM Kinase Is Required for Telomere Elongation in Mouse and Human Cells. Lee SS, Bohrson C, Pike AM, Wheelan SJ, Greider CW. Cell Rep. 2015 Nov 24;13(8):1623-32. doi: 10.1016/j.celrep.2015.10.035. Epub 2015 Nov 12. PubMed |
| Inhibition of KDM6 activity during murine ESC differentiation induces DNA damage. Hofstetter C, Kampka JM, Huppertz S, Weber H, Schlosser A, Muller AM, Becker M. J Cell Sci. 2016 Feb 15;129(4):788-803. doi: 10.1242/jcs.175174. Epub 2016 Jan 12. PubMed |
| HELB Is a Feedback Inhibitor of DNA End Resection. Tkac J, Xu G, Adhikary H, Young JT, Gallo D, Escribano-Diaz C, Krietsch J, Orthwein A, Munro M, Sol W, Al-Hakim A, Lin ZY, Jonkers J, Borst P, Brown GW, Gingras AC, Rottenberg S, Masson JY, Durocher D. Mol Cell. 2016 Feb 4;61(3):405-18. doi: 10.1016/j.molcel.2015.12.013. Epub 2016 Jan 7. PubMed |
| Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance. Krumm A, Barckhausen C, Kucuk P, Tomaszowski KH, Loquai C, Fahrer J, Kramer OH, Kaina B, Roos WP. Cancer Res. 2016 May 15;76(10):3067-77. doi: 10.1158/0008-5472.CAN-15-2680. Epub 2016 Mar 15. PubMed |
| Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin. Robert C, Nagaria PK, Pawar N, Adewuyi A, Gojo I, Meyers DJ, Cole PA, Rassool FV. Leuk Res. 2016 Jun;45:14-23. doi: 10.1016/j.leukres.2016.03.007. Epub 2016 Mar 30. PubMed |
| SQSTM1/p62 mediates crosstalk between autophagy and the UPS in DNA repair. Hewitt G, Carroll B, Sarallah R, Correia-Melo C, Ogrodnik M, Nelson G, Otten EG, Manni D, Antrobus R, Morgan BA, von Zglinicki T, Jurk D, Seluanov A, Gorbunova V, Johansen T, Passos JF, Korolchuk VI. Autophagy. 2016 Oct 2;12(10):1917-1930. Epub 2016 Jul 8. PubMed |
| Cyclin A2 promotes DNA repair in the brain during both development and aging. Gygli PE, Chang JC, Gokozan HN, Catacutan FP, Schmidt TA, Kaya B, Goksel M, Baig FS, Chen S, Griveau A, Michowski W, Wong M, Palanichamy K, Sicinski P, Nelson RJ, Czeisler C, Otero JJ. Aging (Albany NY). 2016 Jul;8(7):1540-70. doi: 10.18632/aging.100990. PubMed |
| Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib. Wilson AJ, Sarfo-Kantanka K, Barrack T, Steck A, Saskowski J, Crispens MA, Khabele D. Gynecol Oncol. 2016 Oct;143(1):143-51. doi: 10.1016/j.ygyno.2016.07.088. Epub 2016 Jul 19. PubMed |
| CDK1 phosphorylates WRN at collapsed replication forks. Palermo V, Rinalducci S, Sanchez M, Grillini F, Sommers JA, Brosh RM Jr, Zolla L, Franchitto A, Pichierri P. Nat Commun. 2016 Sep 16;7:12880. doi: 10.1038/ncomms12880. PubMed |
| CHK1 and RAD51 activation after DNA damage is regulated via urokinase receptor/TLR4 signaling. Narayanaswamy PB, Tkachuk S, Haller H, Dumler I, Kiyan Y. Cell Death Dis. 2016 Sep 29;7(9):e2383. doi: 10.1038/cddis.2016.291. PubMed |
| Assessing the Effect of Class I Histone Deacetylase Activity on DNA Double-Strand Break Repair by Homologous Recombination. Krumm A, Roos WP. Methods Mol Biol. 2017;1510:115-123. PubMed |
| FLT3 and JAK2 Mutations in Acute Myeloid Leukemia Promote Interchromosomal Homologous Recombination and the Potential for Copy Neutral Loss of Heterozygosity. Gaymes TJ, Mohamedali A, Eiliazadeh AL, Darling D, Mufti GJ. Cancer Res. 2017 Apr 1;77(7):1697-1708. doi: 10.1158/0008-5472.CAN-16-1678. Epub 2017 Jan 20. PubMed |
| TOPBP1(Dpb11) plays a conserved role in homologous recombination DNA repair through the coordinated recruitment of 53BP1(Rad9). Liu Y, Cussiol JR, Dibitetto D, Sims JR, Twayana S, Weiss RS, Freire R, Marini F, Pellicioli A, Smolka MB. J Cell Biol. 2017 Mar 6;216(3):623-639. doi: 10.1083/jcb.201607031. Epub 2017 Feb 22. PubMed |
| Localisation of Nup153 and SENP1 to nuclear pore complexes is required for 53BP1-mediated DNA double-strand break repair. Duheron V, Nilles N, Pecenko S, Martinelli V, Fahrenkrog B. J Cell Sci. 2017 Jul 15;130(14):2306-2316. doi: 10.1242/jcs.198390. Epub 2017 Jun 2. PubMed |
| High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway. Wallace NA, Khanal S, Robinson KL, Wendel SO, Messer JJ, Galloway DA. J Virol. 2017 Sep 27;91(20). pii: JVI.01084-17. doi: 10.1128/JVI.01084-17. Print 2017 Oct 15. PubMed |
| Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis. Chen G, Zhang B, Xu H, Sun Y, Shi Y, Luo Y, Jia H, Wang F. Oncogene. 2017 Dec 14;36(50):6863-6872. doi: 10.1038/onc.2017.297. Epub 2017 Sep 4. PubMed |
| ASF1a Promotes Non-homologous End Joining Repair by Facilitating Phosphorylation of MDC1 by ATM at Double-Strand Breaks. Lee KY, Im JS, Shibata E, Dutta A. Mol Cell. 2017 Oct 5;68(1):61-75.e5. doi: 10.1016/j.molcel.2017.08.021. Epub 2017 Sep 21. PubMed |
Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN.
Arnoult N, Correia A, Ma J, Merlo A, Garcia-Gomez S, Maric M, Tognetti M, Benner CW, Boulton SJ, Saghatelian A, Karlseder J.
Nature. 2017 Sep 20;549(7673):548-552. doi: 10.1038/nature24023.
PubMed
Associated Plasmids |
| The role of Rak in the regulation of stability and function of BRCA1. Kim JL, Ha GH, Campo L, Denning MF, Patel TB, Osipo C, Lin SY, Breuer EK. Oncotarget. 2015 Oct 14;8(49):86799-86815. doi: 10.18632/oncotarget.5717. eCollection 2017 Oct 17. PubMed |
| Negative regulation of BRCA1 by transforming acidic coiled-coil protein 3 (TACC3). Kim JL, Ha GH, Campo L, Breuer EK. Biochem Biophys Res Commun. 2018 Feb 5;496(2):633-640. doi: 10.1016/j.bbrc.2018.01.101. Epub 2018 Jan 19. PubMed |
| BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency. Sun C, Yin J, Fang Y, Chen J, Jeong KJ, Chen X, Vellano CP, Ju Z, Zhao W, Zhang D, Lu Y, Meric-Bernstam F, Yap TA, Hattersley M, O'Connor MJ, Chen H, Fawell S, Lin SY, Peng G, Mills GB. Cancer Cell. 2018 Mar 12;33(3):401-416.e8. doi: 10.1016/j.ccell.2018.01.019. PubMed |
| The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer. Wilson AJ, Stubbs M, Liu P, Ruggeri B, Khabele D. Gynecol Oncol. 2018 Jun;149(3):575-584. doi: 10.1016/j.ygyno.2018.03.049. Epub 2018 Mar 20. PubMed |
| Corylin increases the sensitivity of hepatocellular carcinoma cells to chemotherapy through long noncoding RNA RAD51-AS1-mediated inhibition of DNA repair. Chen CC, Chen CY, Ueng SH, Hsueh C, Yeh CT, Ho JY, Chou LF, Wang TH. Cell Death Dis. 2018 May 1;9(5):543. doi: 10.1038/s41419-018-0575-0. PubMed |
| Targeting p38alpha Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells. Canovas B, Igea A, Sartori AA, Gomis RR, Paull TT, Isoda M, Perez-Montoyo H, Serra V, Gonzalez-Suarez E, Stracker TH, Nebreda AR. Cancer Cell. 2018 Jun 11;33(6):1094-1110.e8. doi: 10.1016/j.ccell.2018.04.010. Epub 2018 May 24. PubMed |
| Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs. Okonkwo A, Mitra J, Johnson GS, Li L, Dashwood WM, Hegde ML, Yue C, Dashwood RH, Rajendran P. Mol Nutr Food Res. 2018 Sep;62(18):e1800228. doi: 10.1002/mnfr.201800228. Epub 2018 Jul 19. PubMed |
| Characterizing DNA Repair Processes at Transient and Long-lasting Double-strand DNA Breaks by Immunofluorescence Microscopy. Murthy V, Dacus D, Gamez M, Hu C, Wendel SO, Snow J, Kahn A, Walterhouse SH, Wallace NA. J Vis Exp. 2018 Jun 8;(136). doi: 10.3791/57653. PubMed |
| ATR-mediated proteome remodeling is a major determinant of homologous recombination capacity in cancer cells. Kim D, Liu Y, Oberly S, Freire R, Smolka MB. Nucleic Acids Res. 2018 Sep 19;46(16):8311-8325. doi: 10.1093/nar/gky625. PubMed |
| FANCA Promotes DNA Double-Strand Break Repair by Catalyzing Single-Strand Annealing and Strand Exchange. Benitez A, Liu W, Palovcak A, Wang G, Moon J, An K, Kim A, Zheng K, Zhang Y, Bai F, Mazin AV, Pei XH, Yuan F, Zhang Y. Mol Cell. 2018 Aug 16;71(4):621-628.e4. doi: 10.1016/j.molcel.2018.06.030. Epub 2018 Jul 26. PubMed |
| Inhibiting homologous recombination decreases extrachromosomal amplification but has no effect on intrachromosomal amplification in methotrexate-resistant colon cancer cells. Cai M, Zhang H, Hou L, Gao W, Song Y, Cui X, Li C, Guan R, Ma J, Wang X, Han Y, Lv Y, Chen F, Wang P, Meng X, Fu S. Int J Cancer. 2019 Mar 1;144(5):1037-1048. doi: 10.1002/ijc.31781. Epub 2018 Sep 29. PubMed |
| Melatonin Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy Through Long Non-Coding RNA RAD51-AS1-Mediated Suppression of DNA Repair. Chen CC, Chen CY, Wang SH, Yeh CT, Su SC, Ueng SH, Chuang WY, Hsueh C, Wang TH. Cancers (Basel). 2018 Sep 10;10(9). pii: cancers10090320. doi: 10.3390/cancers10090320. PubMed |
| CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome. Unoki M, Funabiki H, Velasco G, Francastel C, Sasaki H. J Clin Invest. 2019 Jan 2;129(1):78-92. doi: 10.1172/JCI99751. Epub 2018 Nov 19. PubMed |
| CtIP-Mediated Fork Protection Synergizes with BRCA1 to Suppress Genomic Instability upon DNA Replication Stress. Przetocka S, Porro A, Bolck HA, Walker C, Lezaja A, Trenner A, von Aesch C, Himmels SF, D'Andrea AD, Ceccaldi R, Altmeyer M, Sartori AA. Mol Cell. 2018 Nov 1;72(3):568-582.e6. doi: 10.1016/j.molcel.2018.09.014. Epub 2018 Oct 18. PubMed |
| PARP Inhibition Induces Enrichment of DNA Repair-Proficient CD133 and CD117 Positive Ovarian Cancer Stem Cells. Bellio C, DiGloria C, Foster R, James K, Konstantinopoulos PA, Growdon WB, Rueda BR. Mol Cancer Res. 2019 Feb;17(2):431-445. doi: 10.1158/1541-7786.MCR-18-0594. Epub 2018 Nov 6. PubMed |
| Viral Proteins U41 and U70 of Human Herpesvirus 6A Are Dispensable for Telomere Integration. Wight DJ, Wallaschek N, Sanyal A, Weller SK, Flamand L, Kaufer BB. Viruses. 2018 Nov 21;10(11). pii: v10110656. doi: 10.3390/v10110656. PubMed |
| NF-kappaB and Poly (ADP-ribose) Polymerase 1 Form a Positive Feedback Loop that Regulates DNA Repair in Acute Myeloid Leukemia Cells. Li D, Luo Y, Chen X, Zhang L, Wang T, Zhuang Y, Fan Y, Xu J, Chen Y, Wu L. Mol Cancer Res. 2019 Mar;17(3):761-772. doi: 10.1158/1541-7786.MCR-18-0523. Epub 2018 Dec 17. PubMed |
| FKBP25 participates in DNA double-strand break repair. Dilworth D, Gong F, Miller KM, Nelson CJ. Biochem Cell Biol. 2019 Jan 8. doi: 10.1139/bcb-2018-0328. PubMed |
| Autophagic cell death restricts chromosomal instability during replicative crisis. Nassour J, Radford R, Correia A, Fuste JM, Schoell B, Jauch A, Shaw RJ, Karlseder J. Nature. 2019 Jan;565(7741):659-663. doi: 10.1038/s41586-019-0885-0. Epub 2019 Jan 23. PubMed |
| Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression. Chou FJ, Chen Y, Chen D, Niu Y, Li G, Keng P, Yeh S, Chang C. EBioMedicine. 2019 Feb;40:504-516. doi: 10.1016/j.ebiom.2018.12.050. Epub 2019 Jan 26. PubMed |
| E3 Ubiquitin Ligases RNF20 and RNF40 Are Required for Double-Stranded Break (DSB) Repair: Evidence for Monoubiquitination of Histone H2B Lysine 120 as a Novel Axis of DSB Signaling and Repair. So CC, Ramachandran S, Martin A. Mol Cell Biol. 2019 Apr 2;39(8). pii: MCB.00488-18. doi: 10.1128/MCB.00488-18. Print 2019 Apr 15. PubMed |
| The Role of Marek's Disease Virus UL12 and UL29 in DNA Recombination and the Virus Lifecycle. Previdelli RL, Bertzbach LD, Wight DJ, Vychodil T, You Y, Arndt S, Kaufer BB. Viruses. 2019 Jan 28;11(2). pii: v11020111. doi: 10.3390/v11020111. PubMed |
| Excess growth hormone suppresses DNA damage repair in epithelial cells. Chesnokova V, Zonis S, Barrett R, Kameda H, Wawrowsky K, Ben-Shlomo A, Yamamoto M, Gleeson J, Bresee C, Gorbunova V, Melmed S. JCI Insight. 2019 Feb 7;4(3). pii: 125762. doi: 10.1172/jci.insight.125762. PubMed |
| Depletion of the RNA binding protein HNRNPD impairs homologous recombination by inhibiting DNA-end resection and inducing R-loop accumulation. Alfano L, Caporaso A, Altieri A, Dell'Aquila M, Landi C, Bini L, Pentimalli F, Giordano A. Nucleic Acids Res. 2019 May 7;47(8):4068-4085. doi: 10.1093/nar/gkz076. PubMed |
| High-risk human papillomavirus oncogenes disrupt the Fanconi anemia DNA repair pathway by impairing localization and de-ubiquitination of FancD2. Khanal S, Galloway DA. PLoS Pathog. 2019 Feb 28;15(2):e1007442. doi: 10.1371/journal.ppat.1007442. eCollection 2019 Feb. PubMed |
| Discovery of Isaindigotone Derivatives as Novel Bloom's Syndrome Protein (BLM) Helicase Inhibitors That Disrupt the BLM/DNA Interactions and Regulate the Homologous Recombination Repair. Yin QK, Wang CX, Wang YQ, Guo QL, Zhang ZL, Ou TM, Huang SL, Li D, Wang HG, Tan JH, Chen SB, Huang ZS. J Med Chem. 2019 Mar 28;62(6):3147-3162. doi: 10.1021/acs.jmedchem.9b00083. Epub 2019 Mar 14. PubMed |
| RAD51D splice variants and cancer-associated mutations reveal XRCC2 interaction to be critical for homologous recombination. Baldock RA, Pressimone CA, Baird JM, Khodakov A, Luong TT, Grundy MK, Smith CM, Karpenshif Y, Bratton-Palmer DS, Prakash R, Jasin M, Garcin EB, Gon S, Modesti M, Bernstein KA. DNA Repair (Amst). 2019 Apr;76:99-107. doi: 10.1016/j.dnarep.2019.02.008. Epub 2019 Feb 23. PubMed |
| Edition of TFAM gene by CRISPR/Cas9 technology in bovine model. de Oliveira VC, Moreira GSA, Bressan FF, Gomes Mariano Junior C, Roballo KCS, Charpentier M, Concordet JP, Meirelles FV, Ambrosio CE. PLoS One. 2019 Mar 7;14(3):e0213376. doi: 10.1371/journal.pone.0213376. eCollection 2019. PubMed |
| Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapy. Pfitzer L, Moser C, Gegenfurtner F, Arner A, Foerster F, Atzberger C, Zisis T, Kubisch-Dohmen R, Busse J, Smith R, Timinszky G, Kalinina OV, Muller R, Wagner E, Vollmar AM, Zahler S. Cell Death Dis. 2019 Apr 3;10(4):302. doi: 10.1038/s41419-019-1546-9. PubMed |
| RNase A treatment and reconstitution with DNA damage response RNA in living cells as a tool to study the role of non-coding RNA in the formation of DNA damage response foci. Michelini F, Rossiello F, d'Adda di Fagagna F, Francia S. Nat Protoc. 2019 May;14(5):1489-1508. doi: 10.1038/s41596-019-0147-5. Epub 2019 Apr 8. PubMed |
| N(6)-Methylation of Adenosine of FZD10 mRNA Contributes to PARP Inhibitor Resistance. Fukumoto T, Zhu H, Nacarelli T, Karakashev S, Fatkhutdinov N, Wu S, Liu P, Kossenkov AV, Showe LC, Jean S, Zhang L, Zhang R. Cancer Res. 2019 Jun 1;79(11):2812-2820. doi: 10.1158/0008-5472.CAN-18-3592. Epub 2019 Apr 9. PubMed |
| RB1 Deletion in Retinoblastoma Protein Pathway-Disrupted Cells Results in DNA Damage and Cancer Progression. Marshall AE, Roes MV, Passos DT, DeWeerd MC, Chaikovsky AC, Sage J, Howlett CJ, Dick FA. Mol Cell Biol. 2019 Jul 29;39(16). pii: MCB.00105-19. doi: 10.1128/MCB.00105-19. Print 2019 Aug 15. PubMed |
| MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer. Lai J, Yang H, Zhu Y, Ruan M, Huang Y, Zhang Q. BMC Cancer. 2019 Jun 18;19(1):602. doi: 10.1186/s12885-019-5798-7. PubMed |
| Activation of Wnt signaling promotes olaparib resistant ovarian cancer. Yamamoto TM, McMellen A, Watson ZL, Aguilera J, Ferguson R, Nurmemmedov E, Thakar T, Moldovan GL, Kim H, Cittelly DM, Joglar AM, Brennecke EP, Wilson H, Behbakht K, Sikora MJ, Bitler BG. Mol Carcinog. 2019 Jun 10. doi: 10.1002/mc.23064. PubMed |
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites.
Jayavaradhan R, Pillis DM, Goodman M, Zhang F, Zhang Y, Andreassen PR, Malik P.
Nat Commun. 2019 Jun 28;10(1):2866. doi: 10.1038/s41467-019-10735-7.
PubMed
Associated Plasmids |
| Inhibition of CD4/CDK6 Enhances Radiosensitivity of HPV Negative Head and Neck Squamous Cell Carcinomas. Gottgens EL, Bussink J, Leszczynska KB, Peters H, Span PN, Hammond EM. Int J Radiat Oncol Biol Phys. 2019 Jul 2. pii: S0360-3016(19)33419-4. doi: 10.1016/j.ijrobp.2019.06.2531. PubMed |
| RIF1 promotes replication fork protection and efficient restart to maintain genome stability. Mukherjee C, Tripathi V, Manolika EM, Heijink AM, Ricci G, Merzouk S, de Boer HR, Demmers J, van Vugt MATM, Ray Chaudhuri A. Nat Commun. 2019 Jul 23;10(1):3287. doi: 10.1038/s41467-019-11246-1. PubMed |
| LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL. Parvin S, Ramirez-Labrada A, Aumann S, Lu X, Weich N, Santiago G, Cortizas EM, Sharabi E, Zhang Y, Sanchez-Garcia I, Gentles AJ, Roberts E, Bilbao-Cortes D, Vega F, Chapman JR, Verdun RE, Lossos IS. Cancer Cell. 2019 Sep 16;36(3):237-249.e6. doi: 10.1016/j.ccell.2019.07.007. Epub 2019 Aug 22. PubMed |
| Chromatin-bound cGAS is an inhibitor of DNA repair and hence accelerates genome destabilization and cell death. Jiang H, Xue X, Panda S, Kawale A, Hooy RM, Liang F, Sohn J, Sung P, Gekara NO. EMBO J. 2019 Oct 4;38(21):e102718. doi: 10.15252/embj.2019102718. Epub 2019 Sep 23. PubMed |
| Differential Requirements for the RAD51 Paralogs in Genome Repair and Maintenance in Human Cells. Garcin EB, Gon S, Sullivan MR, Brunette GJ, Cian A, Concordet JP, Giovannangeli C, Dirks WG, Eberth S, Bernstein KA, Prakash R, Jasin M, Modesti M. PLoS Genet. 2019 Oct 4;15(10):e1008355. doi: 10.1371/journal.pgen.1008355. eCollection 2019 Oct. PubMed |
| Synergism between ATM and PARP1 Inhibition Involves DNA Damage and Abrogating the G2 DNA Damage Checkpoint. Mak JPY, Ma HT, Poon RYC. Mol Cancer Ther. 2020 Jan;19(1):123-134. doi: 10.1158/1535-7163.MCT-19-0474. Epub 2019 Oct 9. PubMed |
| ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer. Kanakkanthara A, Huntoon CJ, Hou X, Zhang M, Heinzen EP, O'Brien DR, Oberg AL, John Weroha S, Kaufmann SH, Karnitz LM. Nat Commun. 2019 Oct 11;10(1):4632. doi: 10.1038/s41467-019-12610-x. PubMed |
| 53BP1 Enforces Distinct Pre- and Post-resection Blocks on Homologous Recombination. Callen E, Zong D, Wu W, Wong N, Stanlie A, Ishikawa M, Pavani R, Dumitrache LC, Byrum AK, Mendez-Dorantes C, Martinez P, Canela A, Maman Y, Day A, Kruhlak MJ, Blasco MA, Stark JM, Mosammaparast N, McKinnon PJ, Nussenzweig A. Mol Cell. 2020 Jan 2;77(1):26-38.e7. doi: 10.1016/j.molcel.2019.09.024. Epub 2019 Oct 22. PubMed |
| PML isoform expression and DNA break location relative to PML nuclear bodies impacts the efficiency of homologous recombination. Attwood KM, Salsman J, Chung D, Mathavarajah S, Van Iderstine C, Dellaire G. Biochem Cell Biol. 2019 Oct 31. doi: 10.1139/bcb-2019-0115. PubMed |
| Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma. Watson ZL, Yamamoto TM, McMellen A, Kim H, Hughes CJ, Wheeler LJ, Post MD, Behbakht K, Bitler BG. Clin Epigenetics. 2019 Nov 27;11(1):165. doi: 10.1186/s13148-019-0758-2. PubMed |
| Non-canonical regulation of homologous recombination DNA repair by the USP9X deubiquitylase. O'Dea R, Santocanale C. J Cell Sci. 2020 Feb 12;133(3):jcs233437. doi: 10.1242/jcs.233437. PubMed |
| Synergistic lethality between PARP-trapping and alantolactone-induced oxidative DNA damage in homologous recombination-proficient cancer cells. Wang H, Zhang S, Song L, Qu M, Zou Z. Oncogene. 2020 Apr;39(14):2905-2920. doi: 10.1038/s41388-020-1191-x. Epub 2020 Feb 6. PubMed |
| Olaparib and enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling. Zhao J, Sun Y, Lin H, Chou F, Xiao Y, Jin R, Cai X, Chang C. FASEB J. 2020 Apr;34(4):5877-5891. doi: 10.1096/fj.201903045RR. Epub 2020 Mar 5. PubMed |
| Histone demethylase JMJD1A promotes expression of DNA repair factors and radio-resistance of prostate cancer cells. Fan L, Xu S, Zhang F, Cui X, Fazli L, Gleave M, Clark DJ, Yang A, Hussain A, Rassool F, Qi J. Cell Death Dis. 2020 Apr 1;11(4):214. doi: 10.1038/s41419-020-2405-4. PubMed |
| High-throughput functional evaluation of BRCA2 variants of unknown significance. Ikegami M, Kohsaka S, Ueno T, Momozawa Y, Inoue S, Tamura K, Shimomura A, Hosoya N, Kobayashi H, Tanaka S, Mano H. Nat Commun. 2020 May 22;11(1):2573. doi: 10.1038/s41467-020-16141-8. PubMed |
| Protein expression profiling identifies differential modulation of homologous recombination by platinum-based antitumor agents. He G, Xie X, Siddik ZH. Cancer Chemother Pharmacol. 2020 Jun;85(6):1129-1140. doi: 10.1007/s00280-020-04085-1. Epub 2020 May 28. PubMed |
| BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice. Perkail S, Andricovich J, Kai Y, Tzatsos A. Nat Commun. 2020 Jun 15;11(1):3018. doi: 10.1038/s41467-020-16589-8. PubMed |
| Computational inference of cancer-specific vulnerabilities in clinical samples. Jang K, Park MJ, Park JS, Hwangbo H, Sung MK, Kim S, Jung J, Lee JW, Ahn SH, Chang S, Choi JK. Genome Biol. 2020 Jun 29;21(1):155. doi: 10.1186/s13059-020-02077-1. PubMed |
| Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic Targeting. Bradbury A, O'Donnell R, Drew Y, Curtin NJ, Sharma Saha S. Cancers (Basel). 2020 Jul 17;12(7). pii: cancers12071939. doi: 10.3390/cancers12071939. PubMed |
| The RNA transport factor PHAX is required for proper histone H2AX expression and DNA damage response. Machitani M, Taniguchi I, McCloskey A, Suzuki T, Ohno M. RNA. 2020 Nov;26(11):1716-1725. doi: 10.1261/rna.074625.120. Epub 2020 Aug 5. PubMed |
| Interhomolog Homologous Recombination in Mouse Embryonic Stem Cells. Vanoli F, Prakash R, White T, Jasin M. Methods Mol Biol. 2021;2153:127-143. doi: 10.1007/978-1-0716-0644-5_10. PubMed |
| Assessing Homologous Recombination and Interstrand Cross-Link Repair in Embryonal Carcinoma Testicular Germ Cell Tumor Cell Lines. Cavallo F, Caggiano C, Jasin M, Barchi M. Methods Mol Biol. 2021;2195:113-123. doi: 10.1007/978-1-0716-0860-9_9. PubMed |
| Attenuated measles virus overcomes radio and chemoresistance in human breast cancer cells by inhibiting the nonhomologous end joining pathway. Yang B, Shi J, Sun Z, Zhu D, Xu X. Oncol Rep. 2020 Nov;44(5):2253-2264. doi: 10.3892/or.2020.7768. Epub 2020 Sep 16. PubMed |
| The SWI/SNF ATPase BRG1 stimulates DNA end resection and homologous recombination by reducing nucleosome density at DNA double strand breaks and by promoting the recruitment of the CtIP nuclease. Hays E, Nettleton E, Carter C, Morales M, Vo L, Passo M, Velez-Cruz R. Cell Cycle. 2020 Nov;19(22):3096-3114. doi: 10.1080/15384101.2020.1831256. Epub 2020 Oct 12. PubMed |
| ATM-Dependent Recruitment of BRD7 is required for Transcriptional Repression and DNA Repair at DNA Breaks Flanking Transcriptional Active Regions. Hu K, Li Y, Wu W, Xie L, Yan H, Cai Y, Chen D, Jiang Q, Lin L, Chen Z, Liao JY, Zhang Y, Koeffler HP, Yin D, Song E. Adv Sci (Weinh). 2020 Sep 3;7(20):2000157. doi: 10.1002/advs.202000157. eCollection 2020 Oct. PubMed |
| Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors. Neeb A, Herranz N, Arce-Gallego S, Miranda S, Buroni L, Yuan W, Athie A, Casals T, Carmichael J, Rodrigues DN, Gurel B, Rescigno P, Rekowski J, Welti J, Riisnaes R, Gil V, Ning J, Wagner V, Casanova-Salas I, Cordoba S, Castro N, Fenor de la Maza MD, Seed G, Chandran K, Ferreira A, Figueiredo I, Bertan C, Bianchini D, Aversa C, Paschalis A, Gonzalez M, Morales-Barrera R, Suarez C, Carles J, Swain A, Sharp A, Gil J, Serra V, Lord C, Carreira S, Mateo J, de Bono JS. Eur Urol. 2021 Feb;79(2):200-211. doi: 10.1016/j.eururo.2020.10.029. Epub 2020 Nov 8. PubMed |
| Age-associated deficient recruitment of 53BP1 in G1 cells directs DNA double-strand break repair to BRCA1/CtIP-mediated DNA-end resection. Anglada T, Genesca A, Martin M. Aging (Albany NY). 2020 Dec 27;12(24):24872-24893. doi: 10.18632/aging.202419. Epub 2020 Dec 27. PubMed |
| Chk1 promotes non-homologous end joining in G1 through direct phosphorylation of ASF1A. Lee KY, Dutta A. Cell Rep. 2021 Jan 26;34(4):108680. doi: 10.1016/j.celrep.2020.108680. PubMed |
| Lamin B1 acetylation slows the G1 to S cell cycle transition through inhibition of DNA repair. Murray-Nerger LA, Justice JL, Rekapalli P, Hutton JE, Cristea IM. Nucleic Acids Res. 2021 Feb 26;49(4):2044-2064. doi: 10.1093/nar/gkab019. PubMed |
| WNT inhibition creates a BRCA-like state in Wnt-addicted cancer. Kaur A, Lim JYS, Sepramaniam S, Patnaik S, Harmston N, Lee MA, Petretto E, Virshup DM, Madan B. EMBO Mol Med. 2021 Apr 9;13(4):e13349. doi: 10.15252/emmm.202013349. Epub 2021 Mar 4. PubMed |
| CDK1 inhibitor controls G2/M phase transition and reverses DNA damage sensitivity. Sunada S, Saito H, Zhang D, Xu Z, Miki Y. Biochem Biophys Res Commun. 2021 Apr 23;550:56-61. doi: 10.1016/j.bbrc.2021.02.117. Epub 2021 Mar 5. PubMed |
| Targeting HR Repair as a Synthetic Lethal Approach to Increase DNA Damage Sensitivity by a RAD52 Inhibitor in BRCA2-Deficient Cancer Cells. Tseng WC, Chen CY, Chern CY, Wang CA, Lee WC, Chi YC, Cheng SF, Kuo YT, Chiu YC, Tseng ST, Lin PY, Liou SJ, Li YC, Chen CC. Int J Mol Sci. 2021 Apr 23;22(9). pii: ijms22094422. doi: 10.3390/ijms22094422. PubMed |
| SMARCAD1-mediated active replication fork stability maintains genome integrity. Lo CSY, van Toorn M, Gaggioli V, Paes Dias M, Zhu Y, Manolika EM, Zhao W, van der Does M, Mukherjee C, G S C Souto Goncalves J, van Royen ME, French PJ, Demmers J, Smal I, Lans H, Wheeler D, Jonkers J, Chaudhuri AR, Marteijn JA, Taneja N. Sci Adv. 2021 May 5;7(19). pii: 7/19/eabe7804. doi: 10.1126/sciadv.abe7804. Print 2021 May. PubMed |
| RNA transcripts stimulate homologous recombination by forming DR-loops. Ouyang J, Yadav T, Zhang JM, Yang H, Rheinbay E, Guo H, Haber DA, Lan L, Zou L. Nature. 2021 Jun;594(7862):283-288. doi: 10.1038/s41586-021-03538-8. Epub 2021 May 12. PubMed |
| Altered replication stress response due to CARD14 mutations promotes recombination-induced revertant mosaicism. Miyauchi T, Suzuki S, Takeda M, Peh JT, Aiba M, Natsuga K, Fujita Y, Takeichi T, Sakamoto T, Akiyama M, Shimizu H, Nomura T. Am J Hum Genet. 2021 Jun 3;108(6):1026-1039. doi: 10.1016/j.ajhg.2021.04.021. Epub 2021 May 17. PubMed |
| The epigenetic regulator LSH maintains fork protection and genomic stability via MacroH2A deposition and RAD51 filament formation. Xu X, Ni K, He Y, Ren J, Sun C, Liu Y, Aladjem MI, Burkett S, Finney R, Ding X, Sharan SK, Muegge K. Nat Commun. 2021 Jun 10;12(1):3520. doi: 10.1038/s41467-021-23809-2. PubMed |
| VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases. Ekstrom TL, Pathoulas NM, Huehls AM, Kanakkanthara A, Karnitz LM. Mol Cancer Ther. 2021 Sep;20(9):1561-1571. doi: 10.1158/1535-7163.MCT-20-1099. Epub 2021 Jun 17. PubMed |
| Long noncoding RNA NIHCOLE promotes ligation efficiency of DNA double-strand breaks in hepatocellular carcinoma. Unfried JP, Marin-Baquero M, Rivera-Calzada A, Razquin N, Martin-Cuevas EM, de Braganca S, Aicart-Ramos C, McCoy C, Prats-Mari L, Arribas-Bosacoma R, Lee L, Caruso S, Zucman-Rossi J, Sangro B, Williams G, Moreno-Herrero F, Llorca O, Lees-Miller SP, Fortes P. Cancer Res. 2021 Jul 28. pii: 0008-5472.CAN-21-0463. doi: 10.1158/0008-5472.CAN-21-0463. PubMed |
| Shift in MSL1 alternative polyadenylation in response to DNA damage protects cancer cells from chemotherapeutic agent-induced apoptosis. Kunisky AK, Anyaeche VI, Herron RS, Park CY, Hwang HW. Cell Rep. 2021 Oct 12;37(2):109815. doi: 10.1016/j.celrep.2021.109815. PubMed |
| ATR inhibition reverses the resistance of homologous recombination deficient MGMT(low)/MMR(proficient) cancer cells to temozolomide. El Touny LH, Hose C, Connelly J, Harris E, Monks A, Dull AB, Wilsker DF, Hollingshead MG, Gottholm-Ahalt M, Alcoser SY, Mullendore ME, Parchment RE, Doroshow JH, Teicher BA, Rapisarda A. Oncotarget. 2021 Oct 12;12(21):2114-2130. doi: 10.18632/oncotarget.28090. eCollection 2021 Oct 12. PubMed |
| SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro. Jiang H, Mei YF. Viruses. 2021 Oct 13;13(10). pii: v13102056. doi: 10.3390/v13102056. PubMed |
| A non-canonical, interferon-independent signaling activity of cGAMP triggers DNA damage response signaling. Banerjee D, Langberg K, Abbas S, Odermatt E, Yerramothu P, Volaric M, Reidenbach MA, Krentz KJ, Rubinstein CD, Brautigan DL, Abbas T, Gelfand BD, Ambati J, Kerur N. Nat Commun. 2021 Oct 27;12(1):6207. doi: 10.1038/s41467-021-26240-9. PubMed |
| Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response. Kang HG, Hwangbo H, Kim MJ, Kim S, Lee EJ, Park MJ, Kim JW, Kim BG, Cho EH, Chang S, Lee JY, Choi JK. Cancer Res. 2022 Jan 1;82(1):142-154. doi: 10.1158/0008-5472.CAN-21-2023. Epub 2021 Oct 28. PubMed |
| ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its loss confers sensitivity to PARP inhibition. Bakr A, Hey J, Sigismondo G, Liu CS, Sadik A, Goyal A, Cross A, Iyer RL, Muller P, Trauernicht M, Breuer K, Lutsik P, Opitz CA, Krijgsveld J, Weichenhan D, Plass C, Popanda O, Schmezer P. Nucleic Acids Res. 2021 Nov 18;49(20):11666-11689. doi: 10.1093/nar/gkab964. PubMed |
| Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function. Kumar M, Molkentine D, Molkentine J, Bridges K, Xie T, Yang L, Hefner A, Gao M, Bahri R, Dhawan A, Frederick MJ, Seth S, Abdelhakiem M, Beadle BM, Johnson F, Wang J, Shen L, Heffernan T, Sheth A, Ferris RL, Myers JN, Pickering CR, Skinner HD. Nat Commun. 2021 Nov 3;12(1):6340. doi: 10.1038/s41467-021-26570-8. PubMed |
| Elp1 facilitates RAD51-mediated homologous recombination repair via translational regulation. Chen WT, Tseng HY, Jiang CL, Lee CY, Chi P, Chen LY, Lo KY, Wang IC, Lin FJ. J Biomed Sci. 2021 Nov 24;28(1):81. doi: 10.1186/s12929-021-00773-z. PubMed |
| MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance. Mehlich D, Lomiak M, Sobiborowicz A, Mazan A, Dymerska D, Szewczyk LM, Mehlich A, Borowiec A, Prelowska MK, Gorczynski A, Jablonski P, Izycka-Swieszewska E, Nowis D, Marusiak AA. Cell Death Dis. 2021 Nov 27;12(12):1111. doi: 10.1038/s41419-021-04405-0. PubMed |
| UBE2O and USP7 co-regulate RECQL4 ubiquitinylation and homologous recombination-mediated DNA repair. Huang Q, Qin D, Pei D, Vermeulen M, Zhang X. FASEB J. 2022 Jan;36(1):e22112. doi: 10.1096/fj.202100974RRR. PubMed |
| Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer. Wilson AJ, Gupta VG, Liu Q, Yull F, Crispens MA, Khabele D. Neoplasia. 2022 Feb;24(2):63-75. doi: 10.1016/j.neo.2021.12.002. Epub 2021 Dec 20. PubMed |
| TEX10 Promotes the Tumorigenesis and Radiotherapy Resistance of Urinary Bladder Carcinoma by Stabilizing XRCC6. Luo S, Wang W, Feng J, Li R. J Immunol Res. 2021 Dec 20;2021:5975893. doi: 10.1155/2021/5975893. eCollection 2021. PubMed |
| BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage. He DD, Shang XY, Wang N, Wang GX, He KY, Wang L, Han ZG. Oncogene. 2022 Mar;41(10):1397-1409. doi: 10.1038/s41388-022-02176-2. Epub 2022 Jan 11. PubMed |
| DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS‒STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis. Wang Y, Wei B, Wang D, Wu J, Gao J, Zhong H, Sun Y, Xu Q, Liu W, Gu Y, Guo W. Acta Pharm Sin B. 2022 Jan;12(1):262-273. doi: 10.1016/j.apsb.2021.03.043. Epub 2021 Apr 29. PubMed |
| Loss of Claudin-4 Reduces DNA Damage Repair and Increases Sensitivity to PARP Inhibitors. Yamamoto TM, Webb PG, Davis DM, Baumgartner HK, Woodruff ER, Guntupalli SR, Neville M, Behbakht K, Bitler BG. Mol Cancer Ther. 2022 Apr 1;21(4):647-657. doi: 10.1158/1535-7163.MCT-21-0827. PubMed |
| HuR Plays a Role in Double-Strand Break Repair in Pancreatic Cancer Cells and Regulates Functional BRCA1-Associated-Ring-Domain-1(BARD1) Isoforms. Jain A, McCoy M, Coats C, Brown SZ, Addya S, Pelz C, Sears RC, Yeo CJ, Brody JR. Cancers (Basel). 2022 Apr 6;14(7). pii: cancers14071848. doi: 10.3390/cancers14071848. PubMed |
| BRCA2 C-Terminal RAD51-Binding Domain Confers Resistance to DNA-Damaging Agents. Zhu Z, Kitano T, Morimatsu M, Tanaka A, Morioka R, Lin X, Orino K, Yoshikawa Y. Int J Mol Sci. 2022 Apr 6;23(7). pii: ijms23074060. doi: 10.3390/ijms23074060. PubMed |
| Strand asymmetry influences mismatch resolution during a single-strand annealing. Pokusaeva VO, Diez AR, Espinar L, Perez AT, Filion GJ. Genome Biol. 2022 Apr 12;23(1):93. doi: 10.1186/s13059-022-02665-3. PubMed |
| Retraction: Jiang, H.; Mei, Y.-F. SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro. Viruses 2021, 13, 2056. Jiang H, Mei YF. Viruses. 2022 May 10;14(5):1011. doi: 10.3390/v14051011. PubMed |
| LncRNA CTBP1-DT-encoded microprotein DDUP sustains DNA damage response signalling to trigger dual DNA repair mechanisms. Yu R, Hu Y, Zhang S, Li X, Tang M, Yang M, Wu X, Li Z, Liao X, Xu Y, Li M, Chen S, Qian W, Gong LY, Song L, Li J. Nucleic Acids Res. 2022 Aug 12;50(14):8060-8079. doi: 10.1093/nar/gkac611. PubMed |
| Therapeutic targeting of ATR in alveolar rhabdomyosarcoma. Dorado Garcia H, Pusch F, Bei Y, von Stebut J, Ibanez G, Guillan K, Imami K, Gurgen D, Rolff J, Helmsauer K, Meyer-Liesener S, Timme N, Bardinet V, Chamorro Gonzalez R, MacArthur IC, Chen CY, Schulz J, Wengner AM, Furth C, Lala B, Eggert A, Seifert G, Hundsoerfer P, Kirchner M, Mertins P, Selbach M, Lissat A, Dubois F, Horst D, Schulte JH, Spuler S, You D, Dela Cruz F, Kung AL, Haase K, DiVirgilio M, Scheer M, Ortiz MV, Henssen AG. Nat Commun. 2022 Jul 25;13(1):4297. doi: 10.1038/s41467-022-32023-7. PubMed |
| Dipeptidyl peptidase 9 triggers BRCA2 degradation and promotes DNA damage repair. Bolgi O, Silva-Garcia M, Ross B, Pilla E, Kari V, Killisch M, Spitzner M, Stark N, Lenz C, Weiss K, Donzelli L, Gorrell MD, Grade M, Riemer J, Urlaub H, Dobbelstein M, Huber R, Geiss-Friedlander R. EMBO Rep. 2022 Oct 6;23(10):e54136. doi: 10.15252/embr.202154136. Epub 2022 Aug 1. PubMed |
| RAD54B mutations enhance the sensitivity of ovarian cancer cells to poly(ADP-ribose) polymerase (PARP) inhibitors. Liu P, Lin C, Liu L, Lu Z, Tu Z, Liu H. J Biol Chem. 2022 Sep;298(9):102354. doi: 10.1016/j.jbc.2022.102354. Epub 2022 Aug 9. PubMed |
| DDX17 is required for efficient DSB repair at DNA:RNA hybrid deficient loci. Bader AS, Luessing J, Hawley BR, Skalka GL, Lu WT, Lowndes NF, Bushell M. Nucleic Acids Res. 2022 Oct 14;50(18):10487-10502. doi: 10.1093/nar/gkac843. PubMed |
| Distinct roles of treatment schemes and BRCA2 on the restoration of homologous recombination DNA repair and PARP inhibitor resistance in ovarian cancer. Huang TT, Burkett SS, Tandon M, Yamamoto TM, Gupta N, Bitler BG, Lee JM, Nair JR. Oncogene. 2022 Nov;41(46):5020-5031. doi: 10.1038/s41388-022-02491-8. Epub 2022 Oct 12. PubMed |
| Assessing the Effect of Histone Deacetylase Inhibitors on DNA Double-Strand Break Repair by Nonhomologous End Joining. Kramer OH, Diehl T, Roos WP. Methods Mol Biol. 2023;2589:293-302. doi: 10.1007/978-1-0716-2788-4_19. PubMed |
| FOXO3a Mediates Homologous Recombination Repair (HRR) via Transcriptional Activation of MRE11, BRCA1, BRIP1, and RAD50. Inci G, Warkad MS, Kang BG, Lee NK, Suh HW, Lim SS, Kim J, Kim SC, Lee JY. Molecules. 2022 Dec 6;27(23):8623. doi: 10.3390/molecules27238623. PubMed |
| Enhancement of glycolysis-dependent DNA repair regulated by FOXO1 knockdown via PFKFB3 attenuates hyperglycemia-induced endothelial oxidative stress injury. Sun D, Chen S, Li S, Wang N, Zhang S, Xu L, Zhu S, Li H, Gu Q, Xu X, Wei F. Redox Biol. 2023 Feb;59:102589. doi: 10.1016/j.redox.2022.102589. Epub 2022 Dec 25. PubMed |
| Cryo-EM structure of the Mre11-Rad50-Nbs1 complex reveals the molecular mechanism of scaffolding functions. Rotheneder M, Stakyte K, van de Logt E, Bartho JD, Lammens K, Fan Y, Alt A, Kessler B, Jung C, Roos WP, Steigenberger B, Hopfner KP. Mol Cell. 2023 Jan 19;83(2):167-185.e9. doi: 10.1016/j.molcel.2022.12.003. Epub 2022 Dec 27. PubMed |
| BMAL1 collaborates with CLOCK to directly promote DNA double-strand break repair and tumor chemoresistance. Zhang C, Chen L, Sun L, Jin H, Ren K, Liu S, Qian Y, Li S, Li F, Zhu C, Zhao Y, Liu H, Liu Y. Oncogene. 2023 Mar;42(13):967-979. doi: 10.1038/s41388-023-02603-y. Epub 2023 Feb 2. PubMed |
| NQO1 regulates cell cycle progression at the G2/M phase. Oh ET, Kim HG, Kim CH, Lee J, Kim C, Lee JS, Cho Y, Park HJ. Theranostics. 2023 Jan 10;13(3):873-895. doi: 10.7150/thno.77444. eCollection 2023. PubMed |
| N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer. Yang J, Xu P, Chen Z, Zhang X, Xia Y, Fang L, Xie L, Li B, Xu Z. Cancer Lett. 2023 Apr 1;558:216092. doi: 10.1016/j.canlet.2023.216092. Epub 2023 Feb 15. PubMed |
| HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1. Xia R, Hu C, Ye Y, Zhang X, Li T, He R, Zheng S, Wen X, Chen R. Int J Oncol. 2023 Apr;62(4):45. doi: 10.3892/ijo.2023.5493. Epub 2023 Feb 24. PubMed |
| Heavy metal ions exchange driven protein phosphorylation cascade functions in genomic instability in spermatocytes and male infertility. Li RY, Yang D, He YJ, Zhou Y, Li CC, Li LB, Liao MX, Deng ZL, Zhao LT, Zhang TF, Luo Y, Wang YX, Gao YF. Nucleic Acids Res. 2023 Apr 24;51(7):3150-3165. doi: 10.1093/nar/gkad128. PubMed |
| LncRNA CACClnc promotes chemoresistance of colorectal cancer by modulating alternative splicing of RAD51. Zhang X, Ma D, Xuan B, Shi D, He J, Yu M, Xiong H, Ma Y, Shen C, Guo F, Cao Y, Yan Y, Gao Z, Tong T, Zhu X, Fang JY, Chen H, Hong J. Oncogene. 2023 Apr;42(17):1374-1391. doi: 10.1038/s41388-023-02657-y. Epub 2023 Mar 11. PubMed |
| Construction of a mini-RNA replicon in Escherichia coli. Kashiwagi A, Yomo T. Synth Biol (Oxf). 2023 Mar 3;8(1):ysad004. doi: 10.1093/synbio/ysad004. eCollection 2023. PubMed |
| Racial differences in RAD51 expression are regulated by miRNA-214-5P and its inhibition synergizes with olaparib in triple-negative breast cancer. Mani C, Acharya G, Saamarthy K, Ochola D, Mereddy S, Pruitt K, Manne U, Palle K. Breast Cancer Res. 2023 Apr 20;25(1):44. doi: 10.1186/s13058-023-01615-6. PubMed |
| Modular antibodies reveal DNA damage-induced mono-ADP-ribosylation as a second wave of PARP1 signaling. Longarini EJ, Dauben H, Locatelli C, Wondisford AR, Smith R, Muench C, Kolvenbach A, Lynskey ML, Pope A, Bonfiglio JJ, Jurado EP, Fajka-Boja R, Colby T, Schuller M, Ahel I, Timinszky G, O'Sullivan RJ, Huet S, Matic I. Mol Cell. 2023 May 18;83(10):1743-1760.e11. doi: 10.1016/j.molcel.2023.03.027. Epub 2023 Apr 27. PubMed |
| PRAME induces genomic instability in uveal melanoma. Harbour JW, Kurtenbach S, Sanchez M, Kuznetsoff J, Rodriguez D, Weich N, Dollar J, Cruz A, Kurtenbach S, Field M, Decatur C, Sorouri M, Lai F, Shiekhattar R, Pelaez D, Correa Z, Verdun R. Res Sq. 2023 Apr 26:rs.3.rs-2861359. doi: 10.21203/rs.3.rs-2861359/v1. Preprint. PubMed |
| Functional characterization of C21ORF2 association with the NEK1 kinase mutated in human in diseases. Gregorczyk M, Pastore G, Munoz I, Carroll T, Streubel J, Munro M, Lis P, Lange S, Lamoliatte F, Macartney T, Toth R, Brown F, Hastie J, Pereira G, Durocher D, Rouse J. Life Sci Alliance. 2023 May 15;6(7):e202201740. doi: 10.26508/lsa.202201740. Print 2023 Jul. PubMed |
| Kaempferol inhibits non-homologous end joining repair via regulating Ku80 stability in glioma cancer. Chen M, Zhao E, Li M, Xu M, Hao S, Gao Y, Wu X, Li X, Yu Y, Yu Z, Yin Y. Phytomedicine. 2023 Jul 25;116:154876. doi: 10.1016/j.phymed.2023.154876. Epub 2023 May 12. PubMed |
| Nuclear DJ-1 Regulates DNA Damage Repair via the Regulation of PARP1 Activity. Wang ZX, Liu Y, Li YL, Wei Q, Lin RR, Kang R, Ruan Y, Lin ZH, Xue NJ, Zhang BR, Pu JL. Int J Mol Sci. 2023 May 12;24(10):8651. doi: 10.3390/ijms24108651. PubMed |
| Oncogenic Impact of TONSL, a Homologous Recombination Repair Protein at the Replication Fork, in Cancer Stem Cells. Lee H, Ha S, Choi S, Do S, Yoon S, Kim YK, Kim WY. Int J Mol Sci. 2023 May 31;24(11):9530. doi: 10.3390/ijms24119530. PubMed |
| The hydrophilic extract from a new tomato genotype (named DHO) kills cancer cell lines through the modulation of the DNA damage response induced by Campthotecin treatment. Barone D, Iannuzzi CA, Forte IM, Ragosta MC, Cuomo M, Dell'Aquila M, Altieri A, Caporaso A, Camerlingo R, Rigano MM, Monti DM, Barone A, Imbimbo P, Frusciante L, Monda M, D'Angelo M, De Laurentiis M, Giordano A, Alfano L. Front Oncol. 2023 Jun 20;13:1117262. doi: 10.3389/fonc.2023.1117262. eCollection 2023. PubMed |
| mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance. Bu C, Zhao L, Wang L, Yu Z, Zhou J. Oncol Res. 2023 Jun 27;31(4):495-503. doi: 10.32604/or.2023.029309. eCollection 2023. PubMed |
| PC4-mediated Ku complex PARylation facilitates NHEJ-dependent DNA damage repair. Pan Q, Luo P, Shi C. J Biol Chem. 2023 Jul 10;299(8):105032. doi: 10.1016/j.jbc.2023.105032. PubMed |
| Fatty acid oxidation facilitates DNA double-strand break repair by promoting PARP1 acetylation. Yang S, Hwang S, Kim B, Shin S, Kim M, Jeong SM. Cell Death Dis. 2023 Jul 15;14(7):435. doi: 10.1038/s41419-023-05968-w. PubMed |
| Different SWI/SNF complexes coordinately promote R-loop- and RAD52-dependent transcription-coupled homologous recombination. Davo-Martinez C, Helfricht A, Ribeiro-Silva C, Raams A, Tresini M, Uruci S, van Cappellen WA, Taneja N, Demmers JAA, Pines A, Theil AF, Vermeulen W, Lans H. Nucleic Acids Res. 2023 Jul 20:gkad609. doi: 10.1093/nar/gkad609. PubMed |
| Transforming Growth Factor Beta and Epithelial to Mesenchymal Transition Alter Homologous Recombination Repair Gene Expression and Sensitize BRCA Wild-Type Ovarian Cancer Cells to Olaparib. Roberts CM, Rojas-Alexandre M, Hanna RE, Lin ZP, Ratner ES. Cancers (Basel). 2023 Aug 1;15(15):3919. doi: 10.3390/cancers15153919. PubMed |
| RAP80 phase separation at DNA double-strand break promotes BRCA1 recruitment. Qin C, Wang YL, Zhou JY, Shi J, Zhao WW, Zhu YX, Bai SM, Feng LL, Bie SY, Zeng B, Zheng J, Zeng GD, Feng WX, Wan XB, Fan XJ. Nucleic Acids Res. 2023 Oct 13;51(18):9733-9747. doi: 10.1093/nar/gkad686. PubMed |
| Targeting phosphomevalonate kinase enhances radiosensitivity via ubiquitination of the replication protein A1 in lung cancer cells. Park SS, Kwon MR, Ju EJ, Shin SH, Park J, Ko EJ, Son GW, Lee HW, Kim YJ, Moon GJ, Park YY, Song SY, Jeong SY, Choi EK. Cancer Sci. 2023 Sep;114(9):3583-3594. doi: 10.1111/cas.15896. Epub 2023 Jul 5. PubMed |
| Functional evaluation of BRCA1/2 variants of unknown significance with homologous recombination assay and integrative in silico prediction model. Guo Q, Ji S, Takeuchi K, Urasaki W, Suzuki A, Iwasaki Y, Saito H, Xu Z, Arai M, Nakamura S, Momozawa Y, Chiba N, Miki Y, Matsuura M, Sunada S. J Hum Genet. 2023 Dec;68(12):849-857. doi: 10.1038/s10038-023-01194-6. Epub 2023 Sep 20. PubMed |
| Protein Phosphatase 4 Is Required for Centrobin Function in DNA Damage Repair. Rethi-Nagy Z, Abraham E, Sinka R, Juhasz S, Lipinszki Z. Cells. 2023 Sep 6;12(18):2219. doi: 10.3390/cells12182219. PubMed |
| FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner. Pifer PM, Yang L, Kumar M, Xie T, Frederick M, Hefner A, Beadle B, Molkentine D, Molkentine J, Dhawan A, Abdelhakiem M, Osman AA, Leibowitz BJ, Myers JN, Pickering CR, Sandulache VC, Heymach J, Skinner HD. Clin Cancer Res. 2024 Jan 5;30(1):187-197. doi: 10.1158/1078-0432.CCR-23-0964. PubMed |
| Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51. Tao L, Zhou Y, Pan X, Luo Y, Qiu J, Zhou X, Chen Z, Li Y, Xu L, Zhou Y, Zuo Z, Liu C, Wang L, Liu X, Tian X, Su N, Yang Z, Zhang Y, Gou K, Sang N, Liu H, Zou J, Xiao Y, Zhong X, Xu J, Yang X, Xiao K, Liu Y, Yang S, Peng Y, Han J, Cen X, Zhao Y. Nat Commun. 2023 Nov 16;14(1):7430. doi: 10.1038/s41467-023-42850-x. PubMed |
| The phosphorylated trimeric SOSS1 complex and RNA polymerase II trigger liquid-liquid phase separation at double-strand breaks. Long Q, Sebesta M, Sedova K, Haluza V, Alagia A, Liu Z, Stefl R, Gullerova M. Cell Rep. 2023 Dec 26;42(12):113489. doi: 10.1016/j.celrep.2023.113489. Epub 2023 Nov 30. PubMed |
| CDK9-55 guides the anaphase-promoting complex/cyclosome (APC/C) in choosing the DNA repair pathway choice. Alfano L, Iannuzzi CA, Barone D, Forte IM, Ragosta MC, Cuomo M, Mazzarotti G, Dell'Aquila M, Altieri A, Caporaso A, Roma C, Marra L, Boffo S, Indovina P, De Laurentiis M, Giordano A. Oncogene. 2024 Apr;43(17):1263-1273. doi: 10.1038/s41388-024-02982-w. Epub 2024 Mar 4. PubMed |
| Repression of the SUMO-conjugating enzyme UBC9 is associated with lowered double minutes and reduced tumor progression. Wang Y, Zou H, Ji W, Huang M, You B, Sun N, Qiao Y, Liu P, Xu L, Zhang X, Cai M, Kuang Y, Fu S, Sun W, Jia X, Wu J. Cancer Biol Ther. 2024 Dec 31;25(1):2323768. doi: 10.1080/15384047.2024.2323768. Epub 2024 Mar 11. PubMed |
| Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real-world clinical tumor sequencing study. Huang Y, Qiu Y, Ding L, Ren S, Jiang Y, Luo J, Huang J, Yin X, Fu S, Zhao J, Hu K, Liao J. J Pathol Clin Res. 2024 Mar;10(2):e12367. doi: 10.1002/2056-4538.12367. PubMed |
| ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response. Bakr A, Corte GD, Veselinov O, Kelekci S, Chen MM, Lin YY, Sigismondo G, Iacovone M, Cross A, Syed R, Jeong Y, Sollier E, Liu CS, Lutsik P, Krijgsveld J, Weichenhan D, Plass C, Popanda O, Schmezer P. Nucleic Acids Res. 2024 Jun 10;52(10):5698-5719. doi: 10.1093/nar/gkae233. PubMed |
| DNA-PK and ATM drive phosphorylation signatures that antagonistically regulate cytokine responses to herpesvirus infection or DNA damage. Justice JL, Reed TJ, Phelan B, Greco TM, Hutton JE, Cristea IM. Cell Syst. 2024 Apr 17;15(4):339-361.e8. doi: 10.1016/j.cels.2024.03.003. Epub 2024 Apr 8. PubMed |
| The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance. Sanese P, De Marco K, Lepore Signorile M, La Rocca F, Forte G, Latrofa M, Fasano C, Disciglio V, Di Nicola E, Pantaleo A, Bianco G, Spilotro V, Ferroni C, Tubertini M, Labarile N, De Marinis L, Armentano R, Gigante G, Lantone V, Lantone G, Naldi M, Bartolini M, Varchi G, Del Rio A, Grossi V, Simone C. J Exp Clin Cancer Res. 2024 May 30;43(1):151. doi: 10.1186/s13046-024-03078-9. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.